Nyxoah SA (NYXH) stock
NYXHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.86−0.04 (-4.10%)
Close on Nov 18, 2026Market cap $37.13MP/E –Yield –
Nyxoah cash
Cash and short-term investments held at the end of each period.
Nyxoah's cash was €64.12M at Jun 30, 2026. For fiscal 2025 it was €30.00M, down 12.2% from the year before. The highest annual figure on record is €135.51M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €30.00M | -12.2% |
| FY2024 | Dec 31, 2024 | €34.19M | +58.2% |
| FY2023 | Dec 31, 2023 | €21.61M | +20.8% |
| FY2022 | Dec 31, 2022 | €17.89M | -86.8% |
| FY2021 | Dec 31, 2021 | €135.51M | +46.8% |
| FY2020 | Dec 31, 2020 | €92.30M | +1476.4% |
| FY2019 | Dec 31, 2019 | €5.86M | -65.2% |
| FY2018 | Dec 31, 2018 | €16.81M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | €64.12M | +131.3% |
| Q4 FY2025 | Dec 31, 2025 | €30.00M | +38.8% |
| Q2 FY2025 | Jun 30, 2025 | €22.73M | +36.9% |
| Q4 FY2024 | Dec 31, 2024 | €34.19M | +91.1% |
| Q2 FY2024 | Jun 30, 2024 | €27.72M | -69.2% |
| Q4 FY2023 | Dec 31, 2023 | €21.61M | -71.4% |
| Q2 FY2023 | Jun 30, 2023 | €16.60M | -87.7% |
| Q4 FY2022 | Dec 31, 2022 | €17.89M | -87.3% |
| Q3 FY2022 | Sep 30, 2022 | €89.88M | -2.6% |
| Q2 FY2022 | Jun 30, 2022 | €75.60M | +1191.2% |
| Q4 FY2021 | Dec 31, 2021 | €135.51M | +706.4% |
| Q3 FY2021 | Sep 30, 2021 | €140.91M | – |
| Q4 FY2020 | Dec 31, 2020 | €92.30M | – |
| Q4 FY2019 | Dec 31, 2019 | €5.86M | – |
| Q4 FY2018 | Dec 31, 2018 | €16.81M | – |
See a number that looks wrong?